We are proud to back tech-enabled, category-defining startups that transform our health and cure disease.
Enabling the design of the next generation of RNA molecules through deep learning
Connecting data, tech, humans and environments to change how groups analyze information
Developing sustainable, high-quality biomaterials
Enabling novel insights into biology and disease through next-generation protein sequencing
Cancer therapeutics as precise as their targets
Your medications. Delivered in minutes.
Leveraging AAV gene therapy for safe durable expression of cytokine immunotherapies
End-to-end solution for translational proteomics
Developing transformative cell therapies by identifying novel targets for solid tumors